vs
Side-by-side financial comparison of NEPHROS INC (NEPH) and Virgin Galactic Holdings, Inc (SPCE). Click either name above to swap in a different company.
NEPHROS INC is the larger business by last-quarter revenue ($4.7M vs $4.2M, roughly 1.1× Virgin Galactic Holdings, Inc). NEPHROS INC runs the higher net margin — 1.3% vs -2222.2%, a 2223.5% gap on every dollar of revenue. On growth, Virgin Galactic Holdings, Inc posted the faster year-over-year revenue change (125.5% vs 22.2%).
Nephros Inc is a medical technology company that develops and commercializes high-performance water purification systems, infection control products, and renal care solutions. Its offerings are primarily used by hospitals, dialysis clinics, and long-term care facilities across North America to reduce waterborne pathogen risks and improve patient outcomes.
Virgin Galactic Holdings, Inc. is a British-American spaceflight company founded by Richard Branson and the Virgin Group conglomerate, which retains an 11.9% stake through Virgin Investments Limited.
NEPH vs SPCE — Head-to-Head
Income Statement — Q4 FY2025 vs Q2 FY2024
| Metric | | |
|---|---|---|
| Revenue | $4.7M | $4.2M |
| Net Profit | $62.0K | $-93.8M |
| Gross Margin | 58.4% | -546.6% |
| Operating Margin | 0.4% | -2412.1% |
| Net Margin | 1.3% | -2222.2% |
| Revenue YoY | 22.2% | 125.5% |
| Net Profit YoY | -82.2% | 30.2% |
| EPS (diluted) | $0.01 | $-4.36 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $4.7M | — | ||
| Q3 25 | $4.8M | — | ||
| Q2 25 | $4.4M | — | ||
| Q1 25 | $4.9M | — | ||
| Q4 24 | $3.9M | — | ||
| Q3 24 | $3.5M | — | ||
| Q2 24 | $3.3M | $4.2M | ||
| Q1 24 | $3.5M | $2.0M |
| Q4 25 | $62.0K | — | ||
| Q3 25 | $337.0K | — | ||
| Q2 25 | $237.0K | — | ||
| Q1 25 | $558.0K | — | ||
| Q4 24 | $349.0K | — | ||
| Q3 24 | $183.0K | — | ||
| Q2 24 | $-289.0K | $-93.8M | ||
| Q1 24 | $-169.0K | $-102.0M |
| Q4 25 | 58.4% | — | ||
| Q3 25 | 61.2% | — | ||
| Q2 25 | 63.2% | — | ||
| Q1 25 | 64.7% | — | ||
| Q4 24 | 64.0% | — | ||
| Q3 24 | 61.1% | — | ||
| Q2 24 | 58.8% | -546.6% | ||
| Q1 24 | 62.1% | -1038.1% |
| Q4 25 | 0.4% | — | ||
| Q3 25 | 6.6% | — | ||
| Q2 25 | 5.6% | — | ||
| Q1 25 | 11.6% | — | ||
| Q4 24 | 8.2% | — | ||
| Q3 24 | 5.9% | — | ||
| Q2 24 | -9.7% | -2412.1% | ||
| Q1 24 | -5.7% | -5599.9% |
| Q4 25 | 1.3% | — | ||
| Q3 25 | 7.1% | — | ||
| Q2 25 | 5.4% | — | ||
| Q1 25 | 11.4% | — | ||
| Q4 24 | 9.0% | — | ||
| Q3 24 | 5.2% | — | ||
| Q2 24 | -8.9% | -2222.2% | ||
| Q1 24 | -4.8% | -5139.1% |
| Q4 25 | $0.01 | — | ||
| Q3 25 | $0.03 | — | ||
| Q2 25 | $0.02 | — | ||
| Q1 25 | $0.05 | — | ||
| Q4 24 | $0.04 | — | ||
| Q3 24 | $0.02 | — | ||
| Q2 24 | $-0.03 | $-4.36 | ||
| Q1 24 | $-0.02 | $-5.10 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $5.4M | $775.7M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $10.2M | $394.8M |
| Total Assets | $13.6M | $1.1B |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $5.4M | — | ||
| Q3 25 | $5.2M | — | ||
| Q2 25 | $5.1M | — | ||
| Q1 25 | $4.1M | — | ||
| Q4 24 | $3.8M | — | ||
| Q3 24 | $2.5M | — | ||
| Q2 24 | $3.1M | $775.7M | ||
| Q1 24 | $3.6M | $765.2M |
| Q4 25 | $10.2M | — | ||
| Q3 25 | $10.0M | — | ||
| Q2 25 | $9.6M | — | ||
| Q1 25 | $9.3M | — | ||
| Q4 24 | $8.6M | — | ||
| Q3 24 | $8.2M | — | ||
| Q2 24 | $7.9M | $394.8M | ||
| Q1 24 | $8.2M | $417.6M |
| Q4 25 | $13.6M | — | ||
| Q3 25 | $13.2M | — | ||
| Q2 25 | $12.2M | — | ||
| Q1 25 | $11.8M | — | ||
| Q4 24 | $11.2M | — | ||
| Q3 24 | $10.4M | — | ||
| Q2 24 | $11.1M | $1.1B | ||
| Q1 24 | $11.4M | $1.1B |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $230.0K | $-79.1M |
| Free Cash FlowOCF − Capex | — | $-113.5M |
| FCF MarginFCF / Revenue | — | -2690.7% |
| Capex IntensityCapex / Revenue | — | 815.5% |
| Cash ConversionOCF / Net Profit | 3.71× | — |
| TTM Free Cash FlowTrailing 4 quarters | — | $-458.3M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $230.0K | — | ||
| Q3 25 | $99.0K | — | ||
| Q2 25 | $994.0K | — | ||
| Q1 25 | $322.0K | — | ||
| Q4 24 | $1.3M | — | ||
| Q3 24 | $-623.0K | — | ||
| Q2 24 | $-501.0K | $-79.1M | ||
| Q1 24 | $-672.0K | $-113.2M |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | $-113.5M | ||
| Q1 24 | — | $-126.3M |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | -2690.7% | ||
| Q1 24 | — | -6362.8% |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | 0.0% | — | ||
| Q2 24 | — | 815.5% | ||
| Q1 24 | — | 658.5% |
| Q4 25 | 3.71× | — | ||
| Q3 25 | 0.29× | — | ||
| Q2 25 | 4.19× | — | ||
| Q1 25 | 0.58× | — | ||
| Q4 24 | 3.74× | — | ||
| Q3 24 | -3.40× | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
NEPH
| Products | $4.6M | 98% |
| Other | $108.0K | 2% |
SPCE
Segment breakdown not available.
